Ensign Peak Advisors’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-28,143
Closed -$1M 1783
2023
Q1
$1M Buy
28,143
+650
+2% +$23.6K ﹤0.01% 1238
2022
Q4
$1.01M Sell
27,493
-4,950
-15% -$196K ﹤0.01% 1156
2022
Q3
$1.53M Sell
32,443
-5,900
-15% -$381K ﹤0.01% 881
2022
Q2
$2.75M Hold
38,343
0.01% 696
2022
Q1
$3.1M Hold
38,343
0.01% 722
2021
Q4
$3.94M Sell
38,343
-37,250
-49% -$3.58M 0.01% 735
2021
Q3
$6.61M Buy
75,593
+4,900
+7% +$444K 0.01% 541
2021
Q2
$6.33M Buy
70,693
+20,300
+40% +$1.72M 0.01% 567
2021
Q1
$3.82M Sell
50,393
-850
-2% -$64.1K 0.01% 749
2020
Q4
$3.49M Buy
51,243
+850
+2% +$53K 0.01% 760
2020
Q3
$2.68M Hold
50,393
0.01% 821
2020
Q2
$2.94M Hold
50,393
0.01% 783
2020
Q1
$1.99M Sell
50,393
-8,365
-14% -$489K 0.01% 830
2019
Q4
$3.5M Buy
+58,758
New +$3.16M 0.01% 771

Other funds holding SYNH

Ensign Peak Advisors's SYNH Position: Q2 2023 in Review

Ensign Peak Advisors sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 28,143 shares — an estimated $1M sold.

Ensign Peak Advisors first reported a position in SYNH in Q4 2019 and held it in 14 quarters. The position peaked at $6.61M in Q3 2021. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

  • Ensign Peak Advisors reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Ensign Peak Advisors sold 28,143 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $1M.
  • Ensign Peak Advisors first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2019 and held it in 14 quarters.
  • Ensign Peak Advisors's Syneos Health, Inc. Class A Common Stock position peaked at $6.61M in Q3 2021.
  • 317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.